JPH04341195A - Production of optically active mandelic acid - Google Patents
Production of optically active mandelic acidInfo
- Publication number
- JPH04341195A JPH04341195A JP20661991A JP20661991A JPH04341195A JP H04341195 A JPH04341195 A JP H04341195A JP 20661991 A JP20661991 A JP 20661991A JP 20661991 A JP20661991 A JP 20661991A JP H04341195 A JPH04341195 A JP H04341195A
- Authority
- JP
- Japan
- Prior art keywords
- mandelic acid
- optically active
- racemic
- microorganism
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 title claims abstract description 43
- 229960002510 mandelic acid Drugs 0.000 title claims abstract description 18
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 title claims abstract description 17
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 244000005700 microbiome Species 0.000 claims abstract description 37
- 230000001580 bacterial effect Effects 0.000 claims abstract description 15
- IWYDHOAUDWTVEP-ZETCQYMHSA-N (S)-mandelic acid Chemical group OC(=O)[C@@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-ZETCQYMHSA-N 0.000 claims abstract description 11
- IWYDHOAUDWTVEP-SSDOTTSWSA-N (R)-mandelic acid Chemical compound OC(=O)[C@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-SSDOTTSWSA-N 0.000 claims abstract description 10
- 150000001875 compounds Chemical class 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 21
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 241000223252 Rhodotorula Species 0.000 claims description 9
- 241000223218 Fusarium Species 0.000 claims description 8
- 241000228212 Aspergillus Species 0.000 claims description 7
- 241000589516 Pseudomonas Species 0.000 claims description 7
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 claims description 4
- 241000186146 Brevibacterium Species 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract description 30
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 abstract description 9
- 239000013078 crystal Substances 0.000 abstract description 8
- 238000000354 decomposition reaction Methods 0.000 abstract description 7
- 241000589517 Pseudomonas aeruginosa Species 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 230000000813 microbial effect Effects 0.000 abstract description 4
- 239000000203 mixture Substances 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 3
- 239000002253 acid Substances 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 abstract 4
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000012295 chemical reaction liquid Substances 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 23
- 239000002609 medium Substances 0.000 description 12
- 230000003287 optical effect Effects 0.000 description 11
- 239000000047 product Substances 0.000 description 8
- 238000005119 centrifugation Methods 0.000 description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- 229940041514 candida albicans extract Drugs 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 239000012138 yeast extract Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000221778 Fusarium fujikuroi Species 0.000 description 2
- 241000223221 Fusarium oxysporum Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 238000002306 biochemical method Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- 238000011197 physicochemical method Methods 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- -1 racemic mandelic acid ester Chemical class 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- FBOUIAKEJMZPQG-AWNIVKPZSA-N (1E)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol Chemical compound C1=NC=NN1/C(C(O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1Cl FBOUIAKEJMZPQG-AWNIVKPZSA-N 0.000 description 1
- VTESCYNPUGSWKG-UHFFFAOYSA-N (4-tert-butylphenyl)hydrazine;hydrochloride Chemical compound [Cl-].CC(C)(C)C1=CC=C(N[NH3+])C=C1 VTESCYNPUGSWKG-UHFFFAOYSA-N 0.000 description 1
- QAQSNXHKHKONNS-UHFFFAOYSA-N 1-ethyl-2-hydroxy-4-methyl-6-oxopyridine-3-carboxamide Chemical compound CCN1C(O)=C(C(N)=O)C(C)=CC1=O QAQSNXHKHKONNS-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- 241000223253 Rhodotorula glutinis Species 0.000 description 1
- 241000223254 Rhodotorula mucilaginosa Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000000150 Sympathomimetic Substances 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000011914 asymmetric synthesis Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 229940096118 ella Drugs 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 229940127230 sympathomimetic drug Drugs 0.000 description 1
- OOLLAFOLCSJHRE-ZHAKMVSLSA-N ulipristal acetate Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(OC(C)=O)C(C)=O)[C@]2(C)C1 OOLLAFOLCSJHRE-ZHAKMVSLSA-N 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は光学活性マンデル酸の新
規製法に関する。TECHNICAL FIELD The present invention relates to a new method for producing optically active mandelic acid.
【0002】0002
【従来の技術】光学活性マンデル酸は、ペニシリン系、
セファロスポリン系抗生物質及びエフェドリン等の交感
神経作用薬を含む各種医薬品の原料もしくは合成中間体
として有用な化合物である。従来、光学活性マンデル酸
の製法としては、ラセミ体の分別晶析による光学分割法
、クロマトグラフィーによる光学分割法、有機化学的な
不斉合成法等の物理化学的な方法、およびベンゾイルギ
酸を微生物酵素を用いて不斉還元する方法(特開昭57
−198096、同57−198097、同63−32
492)、ラセミ型マンデル酸エステルを不斉加水分解
する方法(特開平2−53497)等の生化学的方法が
知られている。[Prior art] Optically active mandelic acid is a penicillin,
It is a compound useful as a raw material or synthetic intermediate for various pharmaceuticals, including cephalosporin antibiotics and sympathomimetic agents such as ephedrine. Conventionally, methods for producing optically active mandelic acid include physicochemical methods such as optical resolution by fractional crystallization of a racemate, optical resolution by chromatography, organic chemical asymmetric synthesis, and microbial production of benzoylformic acid. A method of asymmetric reduction using an enzyme
-198096, 57-198097, 63-32
Biochemical methods such as 492) and a method for asymmetric hydrolysis of racemic mandelic acid ester (Japanese Unexamined Patent Publication No. 2-53497) are known.
【0003】0003
【発明が解決しようとする課題】しかしながら、上記物
理化学的方法は操作が煩雑であったり、生成物の収率や
光学純度が低い等の難点を有しており、また生化学的方
法はニコチンアデニンジヌクレオチド等の高価な補酵素
を必要としたり、マンデル酸をエステル化する必要があ
りかつ生成物の光学純度も低いという難点があった。[Problems to be Solved by the Invention] However, the above-mentioned physicochemical method has drawbacks such as complicated operations and low product yield and optical purity, and the biochemical method This method has disadvantages in that it requires expensive coenzymes such as adenine dinucleotide, it requires esterification of mandelic acid, and the optical purity of the product is low.
【0004】0004
【課題を解決するための手段】本発明者らは、かかる難
点を解決すべく鋭意研究を重ねた結果、ラセミ型マンデ
ル酸を不斉分解する能力を有する微生物の存在を見いだ
し、本発明を完成するに至った。[Means for Solving the Problem] As a result of intensive research to solve these difficulties, the present inventors discovered the existence of microorganisms that have the ability to asymmetrically decompose racemic mandelic acid, and completed the present invention. I ended up doing it.
【0005】即ち、本発明は一般式(I)That is, the present invention provides general formula (I)
【0006】[0006]
【化1】[Chemical formula 1]
【0007】で示されるラセミ型マンデル酸に、ラセミ
型マンデル酸を不斉分解する能力を有する微生物の培養
液、該培養液から得た菌体又は該菌体の処理物を作用さ
せて一方の光学活性体を分解した後、対掌体を分離、採
取することを特徴とする光学活性マンデル酸の製法であ
る。本発明において原料化合物であるラセミ型マンデル
酸(I)としては、D体及びL体を等量含むものだけで
なく、これら光学活性体を任意の混合割合で共に含むも
のであればいずれも用いることができる。Racemic mandelic acid represented by the following formula is treated with a culture solution of a microorganism having the ability to asymmetrically decompose racemic mandelic acid, microorganisms obtained from the culture solution, or processed products of the microorganisms. This is a method for producing optically active mandelic acid, which is characterized by separating and collecting the enantiomer after decomposing the optically active form. In the present invention, racemic mandelic acid (I), which is a raw material compound, includes not only one containing equal amounts of D-form and L-form, but also any one containing both of these optically active forms in an arbitrary mixing ratio. be able to.
【0008】本発明に使用される微生物としては、ラセ
ミ型マンデル酸を不斉分解する能力を有するものであれ
ばよく、例えばこのような能力を有するカビ、細菌、酵
母等の微生物を好適に使用することができる。具体的に
はカビとしてはギベレラ属、フザリウム属、アスペルギ
ルス属、に属する微生物があげられ、細菌としてはシュ
ードモナス属、又はブレビバクテリウム属に属する微生
物があげられ、酵母としてはロドトルラ属、ロドスポリ
ジウム属に属する微生物があげられる。かかる微生物の
具体例としては、ギベレラ・フジクロイ(Gibber
ella fujikuroi)IFO 5268
、アスペルギルス・シドウイ(Aspergillus
sydowi)IFO 4284、フザリウム・
オキシスポラム(Fusarium oxyspor
um)IFO 5942、シュードモナス・アエルギ
ノーザ(Pseudomonas aerugino
sa)ATCC7700、同OUT 8252、シュ
ードモナス・フルオレセンス(Pseudomonas
fluorescens)IAM 1219、シ
ュードモナス・ポリカラー(Pseudomonas
polycolor)IFO 3918、シュード
モナス・プチダ(Pseudomonas puti
da)ATCC12633、ブレビバクテリウム・アン
モニアゲネス(Brevibacterium am
moniagenes)IAM 1641、ロドトル
ラ・グルティニス(Rhodotorula glu
tinis)IFO 0389、同IFO 075
8、同IFO 0898、同OUT 6152、ロ
ドトルラ・ルブラ(Rhodotorula rub
ra)IFO 0001、同IFO0918、同IF
O 1100、同0UT 6158、ロドスポリジ
ウム・トルロイデス(Rhodosporidium
toruloides)IFO 0559等がある
。
これらは野生株、変異株であってもよくさらにはこれら
の微生物から遺伝子組み換え、細胞融合などの生物工学
的手法により誘導されるものであってもよい。[0008] The microorganisms used in the present invention may be any microorganisms as long as they have the ability to asymmetrically decompose racemic mandelic acid, and for example, microorganisms such as molds, bacteria, and yeasts having such abilities are preferably used. can do. Specifically, molds include microorganisms belonging to the genus Gibberella, Fusarium, and Aspergillus, bacteria include microorganisms belonging to the genus Pseudomonas or Brevibacterium, and yeast include microorganisms belonging to the genus Rhodotorula and Rhodosporidium. Examples include microorganisms belonging to the genus. A specific example of such a microorganism is Gibberella fujikuroi (Gibberella fujikuroi).
ella fujikuroi) IFO 5268
, Aspergillus sidoui (Aspergillus
sydowi) IFO 4284, Fusarium
Fusarium oxysporum
um) IFO 5942, Pseudomonas aerugino
sa) ATCC 7700, same OUT 8252, Pseudomonas fluorescens
Pseudomonas fluorescens IAM 1219, Pseudomonas polycolor
polycolor) IFO 3918, Pseudomonas puti
da) ATCC12633, Brevibacterium ammonium
moniagenes) IAM 1641, Rhodotorula glu
tinis) IFO 0389, IFO 075
8, IFO 0898, OUT 6152, Rhodotorula rubra
ra) IFO 0001, IFO0918, IF
O 1100, 0UT 6158, Rhodosporidium toruroides
(toruloides) IFO 0559, etc. These may be wild strains or mutant strains, or may be derived from these microorganisms by biotechnological techniques such as genetic recombination and cell fusion.
【0009】これら微生物のうち、L−マンデル酸を選
択的に分解する微生物を用いれば目的物としてD−マン
デル酸を得ることができ、D−マンデル酸を選択的に分
解する微生物を用いればL−マンデル酸を得ることがで
きる。上記で例示した微生物のうち、L−マンデル酸を
選択的に分解する微生物としては、ギベレラ属、シュー
ドモナス属、ブレビバクテリウム属、ロドトルラ属、ロ
ドスポリジウム属に属する微生物があげられ、D−マン
デル酸を選択的に分解する微生物としては、フザリウム
属、アスペルギルス属に属する微生物があげられる。Among these microorganisms, if a microorganism that selectively decomposes L-mandelic acid is used, D-mandelic acid can be obtained as the target product, and if a microorganism that selectively decomposes D-mandelic acid is used, L-mandelic acid can be obtained. - Mandelic acid can be obtained. Among the microorganisms exemplified above, microorganisms that selectively decompose L-mandelic acid include microorganisms belonging to the genus Gibberella, Pseudomonas, Brevibacterium, Rhodotorula, and Rhodosporidium; Examples of microorganisms that selectively decompose acids include microorganisms belonging to the genus Fusarium and Aspergillus.
【0010】上記微生物の培養液及び菌体は、例えば当
該微生物を通常この分野において用いうる培地、例えば
慣用の炭素源、窒素源、および無機塩類含有培地中、常
温ないし加温下(好ましくは20〜40℃)かつ好気的
条件下、pH約5〜8で培養し、必要とあれば常法によ
り培養液から菌体を分離、採取して得ることができる。
なお、培養に際しては培地にラセミ型マンデル酸(1)
を約0.001%以上、とりわけ0.1〜1%程度添加
して酵素活性をあげることもできる。[0010] The culture solution and bacterial cells of the above microorganism can be cultured in a medium normally used in this field, such as a medium containing a conventional carbon source, nitrogen source, and inorganic salts, at room temperature or under heating (preferably at 20°C). ~40°C) and under aerobic conditions at a pH of approximately 5 to 8, and if necessary, the bacterial cells can be isolated and collected from the culture solution by a conventional method. In addition, when culturing, racemic mandelic acid (1) is added to the medium.
It is also possible to increase the enzyme activity by adding about 0.001% or more, especially about 0.1 to 1%.
【0011】また、かかる微生物菌体の処理物としては
、例えば、上記微生物の凍結乾燥菌体、アセトン乾燥菌
体、菌体自己消化物、菌体抽出物、菌体磨砕物、菌体の
超音波処理物等があげられ、さらに菌体抽出物から公知
の方法を組み合わせて精製取得した酵素も用いることが
できる。また、本発明の微生物菌体或いは菌体処理物は
、例えばポリアクリルアミド法、含硫多糖ゲル法(カラ
ギーナンゲル法等)、アルギン酸ゲル法、寒天ゲル法等
の公知方法により固定化して使用することもできる。[0011] Examples of the processed products of microorganisms include freeze-dried cells, acetone-dried cells, cell autolysates, cell extracts, crushed cells, and supernatants of the above-mentioned microorganisms. Examples include sonicated products, and enzymes purified from bacterial cell extracts using a combination of known methods can also be used. Furthermore, the microbial cells or treated microbial cells of the present invention may be used after being immobilized by known methods such as the polyacrylamide method, sulfur-containing polysaccharide gel method (carrageenan gel method, etc.), alginate gel method, agar gel method, etc. You can also do it.
【0012】本発明にかかる不斉分解反応は、例えば、
■ラセミ型マンデル酸(I)を含有する培地で上記微生
物を培養することにより実施してもよく、また、■ラセ
ミ型マンデル酸(I)を、適当な溶媒中で上記微生物の
培養液、該培養液から採取した菌体又は該菌体処理物と
接触させることにより実施してもよい。[0012] The asymmetric decomposition reaction according to the present invention includes, for example,
(1) It may be carried out by culturing the above microorganism in a medium containing racemic mandelic acid (I), or (2) racemic mandelic acid (I) is added to the culture solution of the above microorganism in an appropriate solvent. It may be carried out by contacting with bacterial cells collected from a culture solution or a treated product of the bacterial cells.
【0013】当該不斉分解反応を■の方法で実施する場
合、前記培養条件のもとで、ラセミ型マンデル酸(I)
を0.5〜10%、とりわけ1〜5%添加した培地を用
いて微生物を培養することによって実施することができ
る。また、当該不斉分解反応を■の方法で行う場合、反
応液中の基質の濃度は概ね0.05〜10%、とりわけ
0.5〜5%とするのが好ましく、反応は常温ないし加
温下、好ましくは10〜50℃、とりわけ好ましくは2
5〜40℃で好適に進行する。溶媒としては、例えば、
水、エタノール、イソプロピルアルコール、酢酸エチル
、あるいはこれら有機溶媒と水との混液等を使用するこ
とができる。また反応に際しては反応液のpHが5〜1
0とりわけ6〜9となるよう調整するのが好ましい。[0013] When the asymmetric decomposition reaction is carried out by method (2), under the above culture conditions, racemic mandelic acid (I)
This can be carried out by culturing microorganisms using a medium to which 0.5 to 10%, particularly 1 to 5%, of . In addition, when the asymmetric decomposition reaction is carried out by the method (2), the concentration of the substrate in the reaction solution is preferably approximately 0.05 to 10%, particularly 0.5 to 5%, and the reaction is carried out at room temperature or heated. below, preferably 10 to 50°C, particularly preferably 2
It proceeds suitably at 5-40°C. Examples of solvents include:
Water, ethanol, isopropyl alcohol, ethyl acetate, or a mixture of these organic solvents and water can be used. Also, during the reaction, the pH of the reaction solution should be 5 to 1.
It is preferable to adjust the value to 0, especially 6 to 9.
【0014】また、本方法において生菌体を用いる場合
、反応液中に界面活性剤を添加しておけば反応時間の短
縮をはかることができ好ましい。この目的に用いられる
界面活性剤の例としては、臭化セチルピリジニウム、臭
化セチルトリメチルアンモニウム、P−イソオクチルフ
ェニルエーテル(米国、ロームアンドハース社製、商品
名トリトンX−100)等があげられ、反応液に対し0
.0001〜0.1%程度使用するのが好ましい。[0014] Furthermore, when using live microorganisms in this method, it is preferable to add a surfactant to the reaction solution in order to shorten the reaction time. Examples of surfactants used for this purpose include cetylpyridinium bromide, cetyltrimethylammonium bromide, and P-isooctylphenyl ether (manufactured by Rohm and Haas, USA, trade name: Triton X-100). , 0 for the reaction solution
.. It is preferable to use about 0001 to 0.1%.
【0015】かくして得られる光学活性マンデル酸(I
)の単離は常法にしたがって容易に実施することができ
る。例えば、反応液から遠心分離によって菌体等の不溶
性物質を除去したのち反応液のpHを1.0に調整し、
酢酸エチルで抽出後、これを減圧濃縮することにより光
学活性マンデル酸を結晶として採取することができる。The optically active mandelic acid (I
) can be easily isolated according to conventional methods. For example, after removing insoluble substances such as bacterial cells from the reaction solution by centrifugation, the pH of the reaction solution is adjusted to 1.0,
After extraction with ethyl acetate, optically active mandelic acid can be collected as crystals by concentrating it under reduced pressure.
【0016】以下、本発明を実施例により詳細に説明す
る。なお、本明細書中「%」はいずれも「重量/容量
(g/dl)」を意味するものとする。また本実施例
において、マンデル酸の光学活性体の定量は、SUMI
CHIRAL 0A−5000(住化分析センター製
)を用い、高速液体クロマトグラフィーによりおこなっ
た。[0016] The present invention will now be explained in detail by way of examples. In addition, in this specification, "%" refers to "weight/volume".
(g/dl)". In addition, in this example, the optically active form of mandelic acid was quantified using SUMI
The analysis was performed by high performance liquid chromatography using CHIRAL 0A-5000 (manufactured by Sumika Analysis Center).
【0017】[0017]
実施例1
DL−マンデル酸2%、硫酸アンモニウム0.2%、リ
ン酸二水素カリウム0.1%、硫酸マグネシウム0.0
5%、酵母エキス0.02%からなる培地100ml(
pH7.0)を500ml容振盪フラスコに入れ、12
0℃で10分間滅菌した。この培地にシュードモナス・
ポリカラー(Pseudomonaspolycolo
r)IFO 3918を1白金耳接種し、30℃で7
2時間振盪培養した。上記培養液1000mlを遠心分
離して菌体を除去し、上清を得た。該上清に塩酸を加え
てpHを1.0に調整後、酢酸エチル2000mlを加
えて抽出し、酢酸エチル層を分取した後減圧濃縮し、D
−マンデル酸8.78gを粗結晶として得た。この粗結
晶にヘキサン:酢酸エチル=1:1の溶液を添加し、加
熱溶解後冷却して再結晶することにより、D−マンデル
酸の結晶7.02gを得た。
旋光度 :−155.4°(C=2,H2O)光学純
度:100%Example 1 DL-mandelic acid 2%, ammonium sulfate 0.2%, potassium dihydrogen phosphate 0.1%, magnesium sulfate 0.0
100 ml of medium consisting of 5% yeast extract and 0.02% yeast extract (
(pH 7.0) in a 500 ml shake flask, and
Sterilized at 0°C for 10 minutes. In this medium, Pseudomonas
Polycolor (Pseudomonas polycolo)
r) One platinum loop of IFO 3918 was inoculated and incubated at 30°C for 7 days.
The culture was incubated with shaking for 2 hours. 1000 ml of the above culture solution was centrifuged to remove bacterial cells and obtain a supernatant. After adjusting the pH to 1.0 by adding hydrochloric acid to the supernatant, 2000 ml of ethyl acetate was added for extraction, and the ethyl acetate layer was separated and concentrated under reduced pressure.
- 8.78 g of mandelic acid was obtained as crude crystals. A solution of hexane:ethyl acetate = 1:1 was added to the crude crystals, and the mixture was heated and dissolved, then cooled and recrystallized to obtain 7.02 g of D-mandelic acid crystals. Optical rotation: -155.4° (C=2, H2O) Optical purity: 100%
【0018】実施例2
実施例1に示した培地100mlに下記第1表に示す微
生物を接種し、30℃で72時間振盪培養後、培養液に
残存するD−マンデル酸を定量した。D−マンデル酸の
含量は下記第1表の通りであり、また、その対掌体であ
るL−マンデル酸は培養液中から殆ど検出されなかった
。Example 2 100 ml of the culture medium shown in Example 1 was inoculated with the microorganisms shown in Table 1 below, and after culturing with shaking at 30°C for 72 hours, the amount of D-mandelic acid remaining in the culture solution was quantified. The content of D-mandelic acid is as shown in Table 1 below, and its enantiomer L-mandelic acid was hardly detected in the culture solution.
【0019】[0019]
【表1】[Table 1]
【0020】実施例3
DL−マンデル酸0.5%、ポリペプトン1.0%、酵
母エキス1.0%、塩化ナトリウム0.5%からなる培
地100ml(pH7.0)を500ml容振盪フラス
コに入れ、120℃で10分間滅菌した。この培地にシ
ュードモナス・ポリカラー(Pseudomonas
polycolor)IFO 3918を1白金耳
接種し、30℃で20時間培養した。上記培養液100
0mlより遠心分離によって集めた菌体を生理食塩水に
懸濁後、さらに遠心分離により集菌した。該菌体にDL
−マンデル酸2gを含む50mMリン酸緩衝液100m
l(pH7.0)を加え、30℃で60時間不斉分解反
応させることによりL−マンデル酸が完全に分解した。
反応後、遠心分離により除菌し、実施例1と同様に処理
することによりD−マンデル酸820mgを得た。
旋光度 :−155.2°(C=2,H2O)光学純
度:100%Example 3 100 ml of a medium (pH 7.0) consisting of 0.5% DL-mandelic acid, 1.0% polypeptone, 1.0% yeast extract, and 0.5% sodium chloride was placed in a 500 ml shaking flask. , sterilized at 120°C for 10 minutes. Pseudomonas polycolor (Pseudomonas polycolor) was added to this medium.
One platinum loop of IFO 3918 (polycolor) was inoculated and cultured at 30°C for 20 hours. The above culture solution 100
Bacterial cells collected from 0 ml by centrifugation were suspended in physiological saline and further collected by centrifugation. DL to the bacterial cells
- 100ml of 50mM phosphate buffer containing 2g of mandelic acid
L-mandelic acid was completely decomposed by adding L-mandelic acid (pH 7.0) and carrying out an asymmetric decomposition reaction at 30° C. for 60 hours. After the reaction, bacteria were removed by centrifugation and treated in the same manner as in Example 1 to obtain 820 mg of D-mandelic acid. Optical rotation: -155.2° (C=2, H2O) Optical purity: 100%
【0021】実施例4
実施例3に示した培地に下記第2表に示す細菌を接種し
、30℃で20時間培養した。上記培養液100mlよ
り遠心分離によって集めた菌体を生理食塩水に懸濁後さ
らに遠心分離により集菌した。該菌休にDL−マンデル
酸400mgを含む50mMリン酸緩衝液20ml(p
H7.0)を加え、30℃で60時間不斉分解反応させ
た。この反応液のD−マンデル酸の含量は下記第2表の
通りであり、また、その対掌体であるL−マンデル酸は
反応液中から殆ど検出されなかった。Example 4 The bacteria shown in Table 2 below were inoculated into the culture medium shown in Example 3, and cultured at 30°C for 20 hours. The bacterial cells collected from 100 ml of the above culture solution by centrifugation were suspended in physiological saline and further collected by centrifugation. 20 ml of 50 mM phosphate buffer containing 400 mg of DL-mandelic acid (p
H7.0) was added, and the asymmetric decomposition reaction was carried out at 30°C for 60 hours. The content of D-mandelic acid in this reaction solution is shown in Table 2 below, and its enantiomer, L-mandelic acid, was hardly detected in the reaction solution.
【0022】[0022]
【表2】[Table 2]
【0023】実施例5
DL−マンデル酸2%、硫酸アンモニウム0.2%、リ
ン酸二水素カリウム0.1%、硫酸マグネシウム0.0
5%、酵母エキス0.02%からなる培地100ml(
pH7.0)を500ml容振盪フラスコに入れ、12
0℃で10分間滅菌した。この培地にアスペルギルス・
シドウイ(Aspergillus sydowi)
IFO 4284 を1白金耳接種し、30℃で9
6時間振盪培養した。上記培養液1000mlを遠心分
離して菌体を除去し、上清を得た。該上清に塩酸を加え
てpHを1.0に調整後、酢酸エチル2000mlを加
えて抽出し、酢酸エチル層を分取した後減圧濃縮し、L
−マンデル酸8.96gを粗結晶として得た。この粗結
晶にヘキサン:酢酸エチル=1:1の溶液を添加し、加
熱溶解後冷却して再結晶することにより、L−マンデル
酸の結晶7.17gを得た。
旋光度 :+155.2°(C=2,H2O)光学純
度:100%Example 5 DL-mandelic acid 2%, ammonium sulfate 0.2%, potassium dihydrogen phosphate 0.1%, magnesium sulfate 0.0
100 ml of medium consisting of 5% yeast extract and 0.02% yeast extract (
(pH 7.0) in a 500 ml shake flask, and
Sterilized at 0°C for 10 minutes. In this medium, Aspergillus
Aspergillus sydowi
One platinum loop of IFO 4284 was inoculated and incubated at 30°C for 9
The culture was incubated with shaking for 6 hours. 1000 ml of the above culture solution was centrifuged to remove bacterial cells and obtain a supernatant. After adjusting the pH to 1.0 by adding hydrochloric acid to the supernatant, 2000 ml of ethyl acetate was added for extraction, and the ethyl acetate layer was separated and concentrated under reduced pressure.
- 8.96 g of mandelic acid was obtained as crude crystals. A solution of hexane:ethyl acetate = 1:1 was added to the crude crystals, and the mixture was heated and dissolved, then cooled and recrystallized to obtain 7.17 g of L-mandelic acid crystals. Optical rotation: +155.2° (C=2, H2O) Optical purity: 100%
【0024】実施例6
実施例1に示した培地100mlにフザリウム・オキシ
スポラム(Fusarium oxysporum)
IFO 5942を接種し、30℃で96時間振盪培
養した結果、L−マンデル酸が244mg残存し、また
、その対掌体であるD−マンデル酸は培養液中から殆ど
検出されなかった。Example 6 Fusarium oxysporum was added to 100 ml of the medium shown in Example 1.
As a result of inoculating IFO 5942 and culturing with shaking at 30° C. for 96 hours, 244 mg of L-mandelic acid remained, and almost no D-mandelic acid, which is its enantiomer, was detected in the culture solution.
【0025】[0025]
【発明の効果】上記本発明方法は、安価なラセミ型マン
デル酸から光学活性マンデル酸を極めて効率よく取得で
き、しかも光学純度100%の生成物が得られるので、
工業的に有利な製法となるものである。[Effects of the Invention] The method of the present invention allows optically active mandelic acid to be obtained from inexpensive racemic mandelic acid very efficiently, and a product with 100% optical purity can be obtained.
This is an industrially advantageous manufacturing method.
Claims (8)
デル酸を不斉分解する能力を有する微生物の培養液、該
培養液から採取した菌体又は該菌体処理物を作用させて
一方の光学活性体を分解した後、対掌体を分離、採取す
ることを特徴とする光学活性マンデル酸の製法。Claim 1: A culture solution of a microorganism having the ability to asymmetrically decompose racemic mandelic acid, bacterial cells collected from the culture solution, or a treated product of the microorganism is applied to racemic mandelic acid to obtain one optically active compound. A method for producing optically active mandelic acid, which is characterized by separating and collecting the enantiomer after decomposing the body.
、ラセミ型マンデル酸を不斉分解する能力を有する微生
物を培養して一方の光学活性体を分解した後、培養液よ
り対掌体を分離、採取することを特徴とする光学活性マ
ンデル酸の製法。Claim 2: Cultivating a microorganism capable of asymmetrically decomposing racemic mandelic acid in a medium containing racemic mandelic acid to decompose one optically active form, and then separating the enantiomer from the culture solution. A method for producing optically active mandelic acid, which comprises collecting .
デル酸を不斉分解する能力を有する微生物の培養液、該
培養液から採取した菌体又は該菌体処理物と溶媒中で接
触させて一方の光学活性体を分解した後、反応液より対
掌体を分離、採取することを特徴とする光学活性マンデ
ル酸の製法。3. Racemic mandelic acid is brought into contact with a culture solution of a microorganism having the ability to asymmetrically decompose racemic mandelic acid, bacterial cells collected from the culture solution, or a treated product of the bacterial cells in a solvent. A method for producing optically active mandelic acid, which comprises decomposing the optically active form of , and then separating and collecting the enantiomer from the reaction solution.
酸である請求項1、2又は3記載の方法。4. The method according to claim 1, 2 or 3, wherein the enantiomer to be separated and collected is D-mandelic acid.
酸である請求項1、2又は3記載の方法。5. The method according to claim 1, 2 or 3, wherein the enantiomer to be separated and collected is L-mandelic acid.
ム属、ギベレラ属、ブレビバクテリウム属、シュードモ
ナス属、ロドスポリジウム属、ロドトルラ属に属する微
生物である請求項1、2又は3記載の方法。6. The method according to claim 1, 2 or 3, wherein the microorganism belongs to the genus Aspergillus, Fusarium, Gibberella, Brevibacterium, Pseudomonas, Rhodosporidium, or Rhodotorula.
ウム属、シュードモナス属、ロドスポリジウム属、ロド
トルラ属に属する微生物である請求項4記載の方法。7. The method according to claim 4, wherein the microorganism belongs to the genus Gibberella, Previbacterium, Pseudomonas, Rhodosporidium, or Rhodotorula.
ム属に属する微生物である請求項5記載の方法。8. The method according to claim 5, wherein the microorganism belongs to the genus Aspergillus or Fusarium.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20661991A JPH04341195A (en) | 1991-05-14 | 1991-05-14 | Production of optically active mandelic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20661991A JPH04341195A (en) | 1991-05-14 | 1991-05-14 | Production of optically active mandelic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04341195A true JPH04341195A (en) | 1992-11-27 |
Family
ID=16526378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP20661991A Pending JPH04341195A (en) | 1991-05-14 | 1991-05-14 | Production of optically active mandelic acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04341195A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5441888A (en) * | 1992-11-05 | 1995-08-15 | Tanabe Seiyaku Co., Ltd. | Process for producing D-mandelic acid from benzoylformic acid |
AT500468A1 (en) * | 2000-04-17 | 2006-01-15 | Dsm Fine Chem Austria Gmbh | PROCESS FOR THE PREPARATION OF OPTICALLY AND CHEMICALLY HIGH-PURITY (R) OR (S) -HYDROXYCARBOXYLIC ACIDS |
WO2010098505A1 (en) * | 2009-02-27 | 2010-09-02 | 学校法人慶應義塾 | Process for producing novel optically active mandelic acid and derivative thereof |
-
1991
- 1991-05-14 JP JP20661991A patent/JPH04341195A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5441888A (en) * | 1992-11-05 | 1995-08-15 | Tanabe Seiyaku Co., Ltd. | Process for producing D-mandelic acid from benzoylformic acid |
AT500468A1 (en) * | 2000-04-17 | 2006-01-15 | Dsm Fine Chem Austria Gmbh | PROCESS FOR THE PREPARATION OF OPTICALLY AND CHEMICALLY HIGH-PURITY (R) OR (S) -HYDROXYCARBOXYLIC ACIDS |
WO2010098505A1 (en) * | 2009-02-27 | 2010-09-02 | 学校法人慶應義塾 | Process for producing novel optically active mandelic acid and derivative thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH11196890A (en) | Production of optically active 3-quinuclidinol | |
WO2007026860A1 (en) | METHOD FOR PRODUCTION OF OPTICALLY ACTIVE α-HYDROXYCARBOXYLIC ACID | |
JPS63273486A (en) | Production of 1-(4-methoxyphenyl)-2-aminopropane | |
JP3140549B2 (en) | Method for separating optical isomers of α-substituted carboxylic acids | |
JPH04341195A (en) | Production of optically active mandelic acid | |
US5441888A (en) | Process for producing D-mandelic acid from benzoylformic acid | |
JP2696127B2 (en) | Method for producing optically active 2-hydroxycarboxylic acid | |
JP3532922B2 (en) | (R) -2-Amino-1-phenylethanol or a method for producing a halogen-substituted product thereof, optically active phenylserine or a method for producing a halogen-substituted product thereof, novel compound 3- (3-chlorophenyl) serine | |
JP2005117905A (en) | Method for producing optically active 1-benzyl-3-pyrrolidinol | |
JP3146640B2 (en) | Method for producing benzoylformic acid | |
JP2566960B2 (en) | Method for producing (R) -r-substituted-β-hydroxybutyric acid ester | |
JP2786500B2 (en) | Production method of optically active 1,3-butanediol | |
JP3055711B2 (en) | Method for producing optically active (S) -3-phenyl-1,3-propanediol | |
JP2624296B2 (en) | Method for producing γ-halo-β-hydroxybutyrate | |
JP2946055B2 (en) | Method for producing optically active (S)-(+)-3-halo-1,2-propanediol | |
JP2828720B2 (en) | Method for producing optically active 1,3-butanediol | |
JPS6125359B2 (en) | ||
JP2883713B2 (en) | Method for producing optically active 3-phenyl-1,3-propanediol | |
JPH04152895A (en) | Production of optically active 1,3-butanediol | |
JPS6332492A (en) | Production of levorotatory optically active isomer of mandelic acid by enzymatic process | |
JP3192835B2 (en) | Method for producing (S) -1,3-butanediol | |
JPH01222798A (en) | Production of optically active carboxylic acid and antipode ester thereof | |
JPH047678B2 (en) | ||
CA2339910A1 (en) | Method for producing halo-l-tryptophan | |
JPH0576390A (en) | Production of optically active carboxylic acid |